| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dde3cab539add7905533c41b89d67e07 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L7-126
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-3202 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-765
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-715
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-899 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 |
| filingDate |
2012-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25fc319845fe13d74d735d6ebd4bb269
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee19c12c497e58c1bcb71040f7f760cd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ceb381f246672d000ce451575242765 |
| publicationDate |
2015-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
IN-2014CN04055-A |
| abstract |
Methods and compositions for treating medical conditions or improving health in which the composition is ingested in an amount sufficient to modify the proportion of bacteria in a gut microbiome of the individual ingesting the composition. The composition may comprise polydextrose or soluble corn fiber for example. The proportion of Coriobacteriaceae may be decreased to treat conditions such as elevated serum triglycerides nonalcoholic fatty liver disease metabolic syndrome obesity or type 2 diabetes. The proportion of Veillonellaceae may be increased to decrease serum cholesterol. The proportion of Faecalibacterium may be increased to treat inflammatory bowel disease or Chrohn s disease. |
| priorityDate |
2011-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |